Pregnancy in a woman with a history of Budd-Chiari syndrome treated by porto-systemic shunt, protein C deficiency and bicornuate uterus

• References

• 1 Dilawary JP. et al. Hepatic outflow obstruction (Budd-Chiari Syndrome): experience with 177 patients and a review of the literature. Medicine 1994; 73: 21-36.
• 2 Janssen HL. et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiences in coagulation factors associated with Budd-Chiari syndrome and portal vein thrombosis: Results of a case control study. Blood 2000; 96: 2364-8.
• 3 Delentre P. et al. Factor V Leiden related Budd- Chiari syndrome. Gut 2001; 48: 264-8.
• 4 Mohanty D. et al. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India. Hepatology 2001; 34: 666-70.
• 5 De Stefano V. et al. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997; 23: 411-8.
• 6 Pelletier S. et al. Antiphospholipid syndrome as the second cause of non- tumorous Budd-Chiari syndrome. J Hepatol 1994; 21: 76-80.
• 7 Valla D. et al. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives: a case-control study. Gastroenterology 1986; 90: 807-11.
• 8 Mentha G. et al. Liver transplantation for Budd- Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol 2006; 44: 520-8.
• 9 Rosenthal T. et al. The Budd-Chiari syndrome after pregnancy. Report of two cases and a review of the literature. Am J Obstet Gynecol 1972; 113: 789-92.
• 10 Khuroo MS, Datta DV. Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. Am J Med 1980; 68: 113-21.
• 11 Vons C. et al. Successful pregnancy after Budd- Chiari syndrome. Lancet 1984; 02: 975.
• 12 Marpeau L. et al. Normal pregnancy after a Budd- Chiari syndrome treated by shunting: apropos of a case, review of the literature [Article in French]. J Gynecol Obstet Biol Reprod (Paris) 1987; 16: 1045-52.
• 13 Lee WM. Pregnancy in patients with chronic liver disease. Gastroenterol Clin North Am 1992; 21: 889-903.
• 14 De Stefano V. et al. Inherited thrombophilia: pathogenesis, clinical syndromes and management. Blood 1996; 87: 3531-44.
• 15 Friederich PW. et al. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient woman: implications for prophylaxis. Ann Intern Med 1996; 125: 955-60.
• 16 Martinelli I. et al. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001; 86: 800-3.
• 17 Boda Z. et al. Low molecular weight heparin as thromboprophylaxis in familial thrombophilia during the whole period of pregnancy. Thromb Haemost 1996; 76: 124-8.
• 18 Sanson BJ. et al. Safety of low molecular weight heparin in pregnancy: a systematic review. Thromb Haemost 1997; 77: 39-43.
• 19 Iturbe-Alessio I. et al. Risks of anticoagulant therapy in pregnant woman with artificial heart valves. N EnglJ Med 1986; 315: 1390-3.
• 20 Acien P. Reproductive performance of women with uterine malformations. Hum Reprod 1993; 08: 122-6.
• 21 Bates SM. et al. Use of antithrombotic agents during pregnancy The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl. 03) 627S-644S.